NeuroOne Medical Technologies Corp (NAS:NMTC)
$ 1.06 -0.03 (-2.75%) Market Cap: 29.17 Mil Enterprise Value: 26.85 Mil PE Ratio: 0 PB Ratio: 7.26 GF Score: 49/100

Q4 2021 Neuroone Medical Technologies Corp Earnings Call Transcript

Dec 15, 2021 / 02:00PM GMT
Release Date Price: $2.35 (+1.29%)
Operator

Good morning, ladies and gentlemen, and welcome to the NeuroOne Medical Technologies Corporation fourth-quarter 2021 earnings call. (Operator Instructions). It is now my pleasure to turn the floor over your host, James Carbonara. Sir, the floor is yours.

James Carbonara
Hayden IR - Partner, IR Strategy & Operations

Thank you, operator, and once again, welcome to the NeuroOne Medical Technologies Corporation fourth-quarter and full-year fiscal 2021 earnings conference call. Today's call will be conducted by the Company's Chief Executive Officer, Dave Rosa; and its Chief Financial Officer, Ron McClurg. Before I turn the call over to Mr. Rosa, I'd like to remind you that this conference call will include forward-looking statements within the meaning of US Federal Securities law with respect to future operations, financial results, events, trends, and performance, which are based on management's beliefs and assumptions as of today's call or other specified date.

Forward-looking statements may involve known and unknown risks, uncertainties and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot